Spike Protein News and Research

RSS

SARS-CoV-2 infection in pets in COVID-19 positive households: A case study

Researchers tested cats and dogs living in households with COVID-19 positive owners in Texas, US. They found that the pets were also infected in more than 25% of households with a positive case.

10 Dec 2020

Reverse phenotyping shows reactive T cell profiles in SARS-CoV-2 infection

A new study appearing as a preprint on the medRxiv* browser in December 2020 employs reverse phenotyping technology to explore T cell responses in COVID-19.

10 Dec 2020

SARS-CoV-2 spike protein mediates acute lung pathology in mice

A study shows that the viral spike protein is adequate by itself to induce macrophage activation in pulmonary tissue and induce acute inflammation.

10 Dec 2020

Researchers develop new serological assay for detection of SARS-CoV-2 antibodies

Researchers at UC Santa Cruz have developed a novel serological assay for the detection of antibodies to SARS-CoV-2, the coronavirus that causes COVID-19.

10 Dec 2020

EKF launches high performance quantitative COVID-SeroKlir antibody test kit

EKF Diagnostics, the global in vitro diagnostics company, announces that it has introduced one of the first tests to precisely measure levels of COVID-19 neutralizing antibodies in individuals.

From EKF Diagnostics 10 Dec 2020

UCI researchers develop noninvasive, at-home saliva test to detect COVID-19

Researchers in the Henry Samueli School of Engineering at the University of California, Irvine announced promising results in the development of a noninvasive at-home antigen test to detect the spike of SARS-CoV-2 proteins in saliva.

9 Dec 2020

Different SARS-CoV-2 neutralization assays are reliable and concordant for antibody monitoring

A recent study by US researchers, currently available on the medRxiv preprint server, evaluated several cell-based assays that are under validation for determining correlates of protection in individuals with symptomatic coronavirus disease (COVID-19) and vaccine studies – and demonstrated their high concordance with both live and pseudotyped virions.

9 Dec 2020

Interim results show Oxford COVID-19 vaccine protects against symptomatic disease

First full results from interim analysis confirm that the Oxford COVID-19 vaccine (AZD1222) has an acceptable safety profile and is efficacious against symptomatic COVID-19 disease, with no hospitalizations or severe disease reported in the COVID-19 vaccine group so far.

9 Dec 2020

Researchers assess the binding behavior of SARS-CoV-2 virus

The binding of a SARS-CoV-2 virus surface protein spike -- a projection from the spherical virus particle -- to the human cell surface protein ACE2 is the first step to infection that may lead to COVID-19 disease.

8 Dec 2020

UC Davis Health joins with Novavax to test a new experimental coronavirus vaccine

Despite the encouraging news of potentially successful COVID-19 vaccine trials, there is not yet an FDA-approved vaccine available. Research into other effective coronavirus vaccines continues, including at UC Davis Health.

8 Dec 2020

FASLG gene may drive cytokine-linked adverse COVID-19 outcomes with age

A new study published on the preprint server bioRxiv in December 2020 reveals the role played by certain genetic factors in this group, in particular the FASLG gene belonging to the tumor necrosis factor (TNF) family.

8 Dec 2020

High-performing multi-immunoassay for early diagnosis and prognosis of COVID-19

A new study published on the preprint server bioRxiv in December 2020 indicates the ability of anti-SARS-CoV-2 antibody titers and time of induction to differentiate between severe and mild COVID-19 and could lead to the development of a prognostic biomarker for use early in the course of the illness.

8 Dec 2020

Spike Protein News and Research

SARS-CoV-2 infection in pets in COVID-19 positive households: A case study

Reverse phenotyping shows reactive T cell profiles in SARS-CoV-2 infection

SARS-CoV-2 spike protein mediates acute lung pathology in mice

Researchers develop new serological assay for detection of SARS-CoV-2 antibodies

EKF launches high performance quantitative COVID-SeroKlir antibody test kit

UCI researchers develop noninvasive, at-home saliva test to detect COVID-19

Different SARS-CoV-2 neutralization assays are reliable and concordant for antibody monitoring

Interim results show Oxford COVID-19 vaccine protects against symptomatic disease

Researchers assess the binding behavior of SARS-CoV-2 virus

UC Davis Health joins with Novavax to test a new experimental coronavirus vaccine

FASLG gene may drive cytokine-linked adverse COVID-19 outcomes with age

High-performing multi-immunoassay for early diagnosis and prognosis of COVID-19

Bioactive tea compounds show potential anti-SARS-CoV-2 activity

Antibody responses to SARS-CoV-2 virus disappear quickly during convalescence, indicates study

The intranasal route of immunization may offer effective protection against SARS-CoV-2

D614/G614 variants of SARS-CoV-2 affect neuronal transmission; G614 better at membrane fusion

STE90-C11, a SARS-CoV-2 neutralizing antibody, shows high inhibition of RBD-ACE2 binding

High-performance ELISA for serology in mild-moderate non-hospitalized COVID-19

Sensitivity of coronavirus antibody tests may be lower than stated on the package

High seroprevalence of short-lived anti-SARS-CoV-2 antibodies in Paris

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News